Phathom Pharmaceuticals (PHAT) Other Gross PP&E Adjustments (2022 - 2025)
Phathom Pharmaceuticals (PHAT) has disclosed Other Gross PP&E Adjustments for 4 consecutive years, with $683000.0 as the latest value for Q4 2025.
- On a quarterly basis, Other Gross PP&E Adjustments fell 72.69% to $683000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $683000.0, a 72.69% decrease, with the full-year FY2025 number at $683000.0, down 72.69% from a year prior.
- Other Gross PP&E Adjustments was $683000.0 for Q4 2025 at Phathom Pharmaceuticals, up from -$3.0 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $2.5 million in Q4 2024 to a low of -$4.8 million in Q2 2022.
- A 4-year average of -$758562.5 and a median of -$1.0 million in 2025 define the central range for Other Gross PP&E Adjustments.
- Peak YoY movement for Other Gross PP&E Adjustments: surged 396.08% in 2024, then tumbled 247.23% in 2025.
- Phathom Pharmaceuticals' Other Gross PP&E Adjustments stood at -$2.6 million in 2022, then skyrocketed by 136.26% to $946000.0 in 2023, then surged by 164.38% to $2.5 million in 2024, then crashed by 72.69% to $683000.0 in 2025.
- Per Business Quant, the three most recent readings for PHAT's Other Gross PP&E Adjustments are $683000.0 (Q4 2025), -$3.0 million (Q3 2025), and -$1.0 million (Q2 2025).